NCT01931007 - Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Bilateral Primary Osteoarthritis of Knee

Interventions

DRUG

Autologous Bone Marrow Aspirate Concentrate

Autologous Bone marrow aspirate will be concentrated using Magellan Cell Separator and stem cell kit according to the Standard Operating Procedures is to be injected in the treatment knee. 5ml of treatment cells will be combined with 10 ml of previously separated platelet poor bone marrow plasma and used for injection under ultrasound guidance into one of the subject's painful knees.

DRUG

Sterile saline

Bacteriostatic 0.9% sodium chloride, preservative free manufactured by Hospira will be injected into the control knee.

Trial Locations (1)

32224

Mayo Clinic Jacksonville, Jacksonville